Dear shareholder partner,

Here are a few exciting media placements published in the past week that we want to make sure are seen by our BioHarvest community. If you want to receive our media coverage as it happens, please subscribe to any of our social media channels.

June 14, 2022: CEO Ilan Sobel’s Op -Ed published in the Jerusalem Post challenges “For its redemption, the pharmaceutical industry must go plant-based”. Read full article

June 8, 2022: Canaccord Genuity published their first investor report on BioHarvest as an “Around the Corner” Biotechnology company. If you are interested in seeing a copy of the Canaccord report, please respond to this email.

BioHarvest in the News

Our Top  News Releases for April – June 2022

May 31, 2022: BIOHARVEST SCIENCES HIRES DR. BRIAN S. CORNBLATT AS CHIEF MEDICAL OFFICER

• “He will help us lead the charge as we take steps to actively expand our line up of clinically based nutraceutical products and move into medicinal prescription products.” CEO Ilan Sobel

May 12, 2022: BIOHARVEST SCIENCES UNVEILS PROFILE OF UNIQUE CANNABIS COMPOSITION

• Full spectrum profile to include major and minor Cannabinoids as well as Terpenes
• Unique trichome structure provides for potentially higher solubility and bio-availability

April 7, 2022: BIOHARVEST SCIENCES INC. ANNOUNCES A PRIVATE PLACEMENT OF UP TO USD $5 MILLION TO FINANCE PRODUCTION FACILITIES AND SCALING OF CORE BUSINESS

• The funds raised will allow the Company to accelerate the growth plan for its polyphenols/antioxidants and Cannabis verticals.

April 6, 2022:  BIOHARVEST SCIENCES INC. REPORTS STRONG Q1 2022 RESULTS ON ALL OF THE COMPANY’S ACTIVITIES

• Reiterating guidance for year-on-year sales orders to grow 2.5-3.5X to USD 5M – 7M
• Started the transition of VINIA® production at new 20 tons/year facility enabling the scaling of VINIA® sales and conversion of current 2 tons/year facility to Cannabis

Want to Learn More?

If you are interested in joining a small group call with our team, we conduct weekly “Coffee With Ilan” sessions, hosted by CEO Ilan Sobel, every Wednesday at 11am PST. These are casual Q+A Zoom calls limited to 3 invitees per call. If you are interested in participating in a session, please contact justin@bioharvest.com for details.

We expect to host our Q2 Shareholder Update  in early July, and we plan to be making major progress announcements through the latter half of 2022. Your feedback and support are critical to our growth as a biotechnology leader – if you are inspired and energized by our progress, please share our news with your network !